Business Context and Reporting Period
Company: SRx Health Solutions, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 14, 2025
Reporting Period: Event-based (Notice received October 14, 2025; Press Release issued October 17, 2025)
Business Context: The Company is a Delaware corporation with its principal executive offices in Tampa, Florida. Its common stock trades on the NYSE American under the symbol "SRXH".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. However, the notice of non-compliance indicates the Company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years, resulting in stockholders' equity below the $4 million threshold required by NYSE American Section 1003(a)(ii).
Material Changes
- Listing Status: The Company received a written notice from NYSE American indicating non-compliance with continued listing standards due to insufficient stockholders' equity.
- Trading Status: The notice has no immediate effect on the listing or trading of the Company's common stock; trading continues under the symbol "SRXH".
- Regulatory Risk: The Company is subject to delisting proceedings if it fails to cure the deficiency within the specified cure period.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to regain compliance by undertaking measures deemed in the best interests of the Company and its shareholders. It is actively engaged in discussions with the NYSE American and is developing a plan of action.
Deadlines and Contingencies:
- Plan Submission Deadline: November 13, 2025 (to submit a plan to regain compliance).
- Compliance Deadline: July 14, 2026 (target date to regain compliance).
- Acceleration Risk: NYSE American may accelerate delisting action if the common stock trades at levels viewed as abnormally low.
Operational Impact: The receipt of the notice does not affect the Company's business, operations, or SEC reporting requirements.
Investor Verification Checklist
- Verify the Company's most recent audited financial statements to confirm the exact stockholders' equity balance and loss history.
- Monitor the submission of the compliance plan by the November 13, 2025 deadline.
- Track the stock price to assess the risk of accelerated delisting due to abnormally low trading levels.
- Review the press release attached as Exhibit 99.1 for additional details on the Company's proposed remediation strategy.